New JerseyAmbulatory Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Ambulatory are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Estimate Benchmark Distance to Benchmark
Adults who had a doctor´s office or clinic visit in the last 12 months who sometimes or never got advice to quit smoking from provider, Medicare managed care 20.5 27.7 Achieved: 26% better
Adult hemodialysis patients with adequate dialysis - (Kt/V) 12 or higher 97.2 96.5 Achieved: 1% better
Adults who had a doctor's office or clinic visit in the last 12 months whose health providers sometimes or never listened carefully to them, Medicare fee-for-service 3.2 3.2 0.3%
Adults who received a blood cholesterol measurement in the last 5 years 81.5 82.3 0.9%
Ratio of observed deaths to expected deaths among Medicare hemodialysis patients 0.9 0.9 1.2%
Children ages 19-35 months who received 1 or more doses of varicella vaccine 92.3 95.7 3.6%
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine 87.0 90.6 4.0%
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine 91.6 95.4 4.0%
Children ages 19-35 months who received 3 or more doses of polio vaccine 93.3 97.3 4.1%
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine 92.4 96.4 4.1%
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine 91.8 96.2 4.5%
Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment 90.9 95.4 4.8%
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 91.1 95.9 5.0%
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 89.1 95.2 6.4%
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine 89.9 96.4 6.7%
Adults who had a doctor's office or clinic visit in the last 12 months whose health providers sometimes or never showed respect for what they had to say, Medicare fee-for-service 2.7 2.4 9.5%
Adult hemodialysis patients who use arteriovenous fistulas as the primary mode of vascular access 65.5 72.8 10.0%
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
Adults age 40 and over with diagnosed diabetes who received at least two hemoglobin A1c measurements in the calendar year 69.4 79.5 12.7%
Adults age 40 and over with diagnosed diabetes who received a dilated eye examination in the calendar year 65.1 75.2 13.4%
Adults age 65 and over who received an influenza vaccination in the last flu season 60.8 70.3 13.5%
Adults who had a doctor's office or clinic visit in the last 12 months whose health providers sometimes or never spent enough time with them, Medicare managed care 3.2 2.8 14.9%
Adults age 65 and over who ever received pneumococcal vaccination 65.7 78.7 16.5%
People age 12 and over treated for substance abuse who completed treatment course 53.8 65.2 17.5%
Adults who had a doctor's office or clinic visit in the last 12 months whose health providers sometimes or never listened carefully to them, Medicare managed care 2.8 2.4 18.0%
Adults who had a doctor´s office or clinic visit in the last 12 months who sometimes or never got advice to quit smoking from provider, Medicare fee-for-service 34.9 28.8 21.0%
Adults age 40 and over with diagnosed diabetes who had their feet checked for sores or irritation in the calendar year 65.8 84.0 21.7%
Adults age 40 and over with diagnosed diabetes who received a flu vaccination in the calendar year 51.3 65.8 22.1%
Adults ages 18-64 at high risk (e.g., COPD) who ever received pneumococcal vaccination 34.7 44.8 22.6%
Adults who needed to see a specialist in the last 12 months who sometimes or never found it easy to see a specialist, Medicare managed care 7.9 6.4 23.0%
Adults ages 18-64 at high risk (e.g., COPD) who received an influenza vaccination in the last flu season 36.7 47.8 23.2%
Breast cancer diagnosed at advanced stage (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and over 93.7 72.8 28.7%
Adults who had a doctor´s office or clinic visit in the last 12 months whose health providers sometimes or never spent enough time with them, Medicare fee-for-service 5.0 3.8 30.8%
Dialysis patients who were registered on a waiting list for transplantation 18.6 28.2 34.0%
Rating of health care 0-6 on a scale from 0 (worst grade) to 10 (best grade) by adults who had a doctor´s office or clinic visit in the last 12 months, Medicare fee-for-service 11.9 8.8 35.8%
Adults who had a doctor's office or clinic visit in the last 12 months whose health providers sometimes or never showed respect for what they had to say, Medicare managed care 2.3 1.7 38.6%
Adult end stage renal disease (ESRD) patients who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy 32.6 54.1 39.7%
Adults who had a doctor's office or clinic visit in the last 12 months whose health providers sometimes or never explained things in a way they could understand, Medicare fee-for-service 3.8 2.7 43.0%
Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional or distant stage) per 100,000 population age 50 and over 67.9 47.2 44.0%
Patients with treated chronic kidney failure who received a transplant within 3 years of date of renal failure 15.3 28.8 46.7%
Rating of health care 0-6 on a scale from 0 (worst grade) to 10 (best grade) by adults who had a doctor´s office or clinic visit in the last 12 months, Medicare managed care 10.7 7.2 48.9%
Adults who needed to see a specialist in the last 12 months who sometimes or never found it easy to see a specialist, Medicare fee-for-service 10.8 7.2 49.3%
Measures That Are Far From Benchmark
Measure Estimate Benchmark Distance to Benchmark
Cervical cancer diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over 11.4 7.6 50.8%
Adults who had a doctor's office or clinic visit in the last 12 months and needed care, tests, or treatment who sometimes or never found it easy to get the care, tests, or treatment, Medicare fee-for-service 8.3 4.4 88.8%
Adults who had a doctor's office or clinic visit in the last 12 months and needed care, tests, or treatment who sometimes or never found it easy to get the care, tests, or treatment, Medicare managed care 9.6 4.9 96.9%
Measures With No Available Benchmark Information or Supplemental Measures
Measure Estimate Benchmark Distance to Benchmark
Percent of hemodialysis patients whose hemoglobin level is less than 10 g/dL 16.4
Patients with end stage renal disease due to diabetes 41.6
Composite measure: Adults ages 50-75 who received any type of colorectal cancer screening 65.8
Composite measure: Children ages 19-35 months who received all recommended vaccines 70.2
Adolescents ages 16-17 years (excluding adolescents who have had varicella) vaccinated with at least 2 doses of varicella 87.2
Adolescent aged 13-15 years who received 3 or more doses of human papillomavirus (HPV) vaccine 36.6
Adolescents ages 13-15 years (excluding adolescents who have had varicella) vaccinated with at least 2 doses of varicella 88.0
Adolescent ages 16-17 years who received 3 or more doses of human papillomavirus (HPV) vaccine 41.4
People who needed to see a doctor but could not because of cost in the past 12 months 12.3
Composite measure: Adults who had a doctor's office or clinic visit in the last 12 months whose health providers sometimes or never listened carefully, explained things clearly, respected what they had to say, and spent enough time with them, Medicare fee 3.7
Composite measure: Adults who had a doctor's office or clinic visit in the last 12 months whose health providers sometimes or never listened carefully, explained things clearly, respected what they had to say, and spent enough time with them, Medicare man 3.3